Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,678	7,149	4,506	3,499	2,040	1,742
Market Cap Growth	67.88%	58.67%	28.76%	71.56%	17.08%	47.34%
Enterprise Value	6,732	6,294	3,819	2,909	1,642	1,388
Last Close Price	262.67	246.54	156.66	124.06	79.22	69.95
PE Ratio	38.40	34.90	50.54	320.10	-	-
Forward PE	33.55	34.89	33.31	-	-	-
PS Ratio	19.73	18.37	15.51	69.02	-	-
PB Ratio	6.29	5.86	4.76	4.49	3.91	2.94
P/TBV Ratio	6.30	5.86	4.76	4.49	3.91	2.94
P/FCF Ratio	40.65	37.84	37.81	-	-	-
P/OCF Ratio	38.23	35.59	36.51	-	-	-
EV/Sales Ratio	17.30	16.18	13.15	57.38	-	-
EV/EBITDA Ratio	41.32	38.64	36.12	-	-	-
EV/EBIT Ratio	41.74	39.02	36.99	-	-	-
EV/FCF Ratio	35.63	33.32	32.04	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.01
Debt / EBITDA Ratio	0.06	0.06	0.07	-	-	-
Debt / FCF Ratio	0.05	0.05	0.06	-	-	-
Net Debt / Equity Ratio	-0.78	-0.78	-0.78	-0.75	-0.72	-0.83
Net Debt / EBITDA Ratio	-5.81	-5.81	-7.02	6.29	3.16	7.37
Net Debt / FCF Ratio	-5.01	-5.01	-6.23	5.83	2.44	4.25
Asset Turnover	0.33	0.33	0.31	0.07	-	-
Inventory Turnover	0.69	0.69	1.20	-	-	-
Quick Ratio	9.28	9.28	6.89	17.35	13.14	17.02
Current Ratio	9.95	9.95	7.28	17.77	13.30	17.18
Return on Equity (ROE)	18.91%	18.91%	10.34%	1.68%	-25.09%	-15.71%
Return on Assets (ROA)	8.44%	8.44%	6.89%	-8.82%	-12.80%	-9.32%
Return on Invested Capital (ROIC)	39.46%	42.60%	31.62%	-40.50%	-76.89%	-74.23%
Return on Capital Employed (ROCE)	13.10%	13.10%	10.80%	-12.40%	-22.90%	-11.60%
Earnings Yield	2.67%	2.86%	1.98%	0.31%	-6.86%	-3.99%
FCF Yield	2.46%	2.64%	2.65%	-2.88%	-7.53%	-6.67%
Buyback Yield / Dilution	-0.71%	-0.71%	-7.16%	-8.87%	-14.85%	-18.15%

Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q